How important is support for patients who self-manage their diabetes?
Read More »Pump Setting Changes May Go Unnoticed
Recently a pump user reported a sudden increase in her glucose levels lasting a couple of days. Her blood sugars were elevated to 275-320mg/dL, with no ketones present. Changing her infusion sets did not help. Nor did rotating to a new injection site or even using a fresh vial of insulin. After reviewing her insulin pump we noticed a symbol on her “home screen” saying that a special feature was running.
Read More »Sam Engel on CompoSIT and VERTIS Trials: DIC Interview
In this Exclusive Interview, Sam Engel talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about diabetes drugs in the pipeline at Merck; clinical trials on sitagliptin and ertugliflozin, including the CompoSIT and VERSIS studies; and the problem of "clinical inertia" in intensifying treatment.
Read More »Sam Engel on Clinical Inertia in Diabetes Treatment: DIC Interview
In this Exclusive Interview transcript, Sam Engel talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about how clinical inertia affects diabetes treatment; clinical trials on sitagliptin and ertugliflozin, including the CompoSIT and VERSIS studies; and diabetes drugs in the Merck pipeline.
Read More »GLP-1RA as Add-on Therapy to SGLT-2 Inhibitor
Combination treatment can help improve glucose levels in patients with elevated HbA1Cs.
Read More »Can Weight Surgery Cause Remission of Type 2 Diabetes?
Gastric bypass surgery is not only for treating obesity.
Read More »Comparison of the Effects of GLP1-RA and SGLT2i
GLP1-RA and SGLT2i reduce atherosclerotic major cardiovascular events (MACE) to a similar degree in patients with established ASCVD.
Read More »Does Metformin Reduce Risk Of Venous Thromboembolism?
Drug said to be possible fix for multiple primary pathophysiologic abnormalities.
Read More »Is Metformin Therapy Safe For Use In Stage 3 Chronic Kidney Disease?
Metformin may help lower the risk of cardiovascular events and death in patients with moderate to severe renal function.
Read More »Sheri Colberg 2018 Complete Interview
Sheri R. Colberg, PhD, FACSM is Professor Emerita of Exercise Science from Old Dominion University and an internationally recognized authority on diabetes and exercise. She is the author of 12 books, 27 book chapters, and over 400 articles. The author of "Exercise and Diabetes: A Clinician's Guide to Prescribing Physical Activity," published by ADA in 2013, she is also the lead author on a new ADA position statement on physical activity and diabetes published last fall. In 2016, she received the ADA Outstanding Educator in Diabetes Award.
Read More »